Tag: Drug discovery

Shigella Infection (Shigellosis) Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

Shigella infection, also known as shigellosis, is a bacterial infection caused by a family of bacteria known as shigella. The main symptom of this infection is diarrhea, and can be passed through direct contact with the bacteria in the stool. Download the sample report @ https://www.pharmaproff.com/request-sample/1072 The other sign and symptoms associated with shigella infection…
Read more

Sepsis Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

Sepsis refers to inflammation throughout the body, as a result of immune response to fight an infection. Severe cases of sepsis can lead to septic shock. According to the data published by the Centers for Disease Control and Prevention, more than one million people suffer from sepsis each year. Download the sample report @ https://www.pharmaproff.com/request-sample/1071…
Read more

Schistosomiasis Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

Schistosomiasis is an acute and chronic disease caused by parasitic worms of the genus Schistosoma, during routine domestic, occupational, agricultural, and recreational activities, which involves infested water exposure. Download the sample report @ https://www.pharmaproff.com/request-sample/1070 School children are more prone to schistosomiasis due to lack of hygiene and certain play habits, such as swimming or fishing…
Read more

Mycoses Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

Mycoses, also known as fungal infections are categorized into different types based on their invasiveness. The different types of mycoses are superficial, cutaneous, subcutaneous, dimorphic systemic, and opportunistic systemic mycoses. Download the sample report @ https://www.pharmaproff.com/request-sample/1068 Superficial mycoses cause fungal infections of the skin or hair shaft. Superficial infections of the epidermis, hair, and nails…
Read more

Mumps Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

Mumps is a transmissible disease caused by the mumps virus and is characterized by swelling of glands in neck and face. Some of the symptoms of this disease are headache, fever, tiredness, loss of appetite, and muscle ache. Download the sample report @ https://www.pharmaproff.com/request-sample/1067 The disease can be transferred from an infected person through coughing;…
Read more

Middle East Respiratory Syndrome (MERS) Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Coronaviruses are a type of viruses that affect the respiratory tract of mammals, including humans. Download the sample report @ https://www.pharmaproff.com/request-sample/1066 Human coronaviruses usually cause mild to moderate cold-like illnesses. However, MERS-CoV is different from any other coronavirus previously found…
Read more

Klebsiella Infections Therapeutics- Pipeline Analysis 2018

Klebsiella infections include different types of infections like bloodstream infections; pneumonia; wound or surgical site infections; and meningitis, caused by the Klebsiella bacteria. The symptoms associated with these infections are high fevers, chills, cough, and shortness of breath. Download the sample report @ https://www.pharmaproff.com/request-sample/1065 Hospitalized patients undergoing treatment for other conditions may be susceptible to these infections. In healthcare…
Read more

Impetigo Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

Impetigo is a common bacterial infection caused by different kinds of bacteria, including streptococcus and staphylococcus. It is a contagious disease and begins with appearance of red sores on any part of the body, which eventually changes to blisters on the body. Download the sample report @ https://www.pharmaproff.com/request-sample/1064 Impetigo is more common in warm and…
Read more

Ischemic Stroke Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

Ischemic stroke develops due to an obstruction within a blood vessel which supply blood to the brain. The underlying condition for this type of obstruction is atherosclerosis, which is characterized by fatty deposition or plaque build-up in the blood vessels. Ischemic stroke is categorized into two types which includes embolic stroke and thrombotic stroke. Download…
Read more

Hemophagocytic Lymphohistiocytosis (HLH) Therapeutics- Pipeline Analysis

Hemophagocytic lymphohistiocytosis (HLH) is a medical condition in which the human body develops large number of activated immune cells, known as macrophages and lymphocytes. Download the sample report at: https://www.pharmaproff.com/request-sample/1039 Person suffering from HLH usually develop symptoms within the first month or year of life. The symptoms of HLH includes cytopenia, fever, enlarged liver or…
Read more